Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the Locus on 5q14.3
Overview
Genetics
Authors
Affiliations
Background: The 22q11.2 deletion syndrome (22q11.2DS; DiGeorge syndrome/velocardiofacial syndrome) occurs in 1 of 4000 live births, and 60% to 70% of affected individuals have congenital heart disease, ranging from mild to severe. In our cohort of 1472 subjects with 22q11.2DS, a total of 62% (n=906) have congenital heart disease and 36% (n=326) of these have tetralogy of Fallot (TOF), comprising the largest subset of severe congenital heart disease in the cohort.
Methods And Results: To identify common genetic variants associated with TOF in individuals with 22q11.2DS, we performed a genome-wide association study using Affymetrix 6.0 array and imputed genotype data. In our cohort, TOF was significantly associated with a genotyped single-nucleotide polymorphism (rs12519770, =2.98×10) in an intron of the adhesion (G-protein-coupled receptor V1) gene on chromosome 5q14.3. There was also suggestive evidence of association between TOF and several additional single-nucleotide polymorphisms in this region. Some genome-wide significant loci in introns or noncoding regions could affect regulation of genes nearby or at a distance. On the basis of this possibility, we examined existing Hi-C chromatin conformation data to identify genes that might be under shared transcriptional regulation within the region on 5q14.3. There are 6 genes in a topologically associated domain of chromatin with , including (Myocyte-specific enhancer factor 2C). is the only gene that is known to affect heart development in mammals and might be of interest with respect to 22q11.2DS.
Conclusions: In conclusion, common variants may contribute to TOF in 22q11.2DS and may function in cardiac outflow tract development.
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.
Cillo F, Coppola E, Habetswallner F, Cecere F, Pignata L, Toriello E Genes (Basel). 2024; 15(3).
PMID: 38540380 PMC: 10969806. DOI: 10.3390/genes15030321.
Clinically Relevant Genetic Considerations for Patients With Tetralogy of Fallot.
Bassett A, Reuter M, Malecki S, Silversides C, Oechslin E CJC Pediatr Congenit Heart Dis. 2024; 2(6Part A):426-439.
PMID: 38161665 PMC: 10755827. DOI: 10.1016/j.cjcpc.2023.10.002.
Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS.
Zhao Y, Wang Y, Shi L, McDonald-McGinn D, Crowley T, McGinn D NPJ Genom Med. 2023; 8(1):17.
PMID: 37463940 PMC: 10354062. DOI: 10.1038/s41525-023-00363-y.
Grassi M, Montenegro M, Zanardo E, Pastorino A, Dorna M, Kim C Arq Bras Cardiol. 2022; 118(1):61-67.
PMID: 35195210 PMC: 8959050. DOI: 10.36660/abc.20190894.
Zhou Y, Bai K, Wang Y, Meng Z, Zhou S, Jiang S Front Cardiovasc Med. 2022; 8:811156.
PMID: 35141295 PMC: 8818757. DOI: 10.3389/fcvm.2021.811156.